Colorectal cancer screening programs targeted at the pre-Medicare population (ages 54-64) could pay for themselves in avoided future Medicare expenditures, according to a study released last week at the American College of Gastroenterology’s annual meeting.
Using a computer simulation program, researchers estimated the total lifetime costs for screening and any subsequent treatment of colorectal cancer in people over age 50, using three different kinds of testing (fecal occult blood test, or FOBT; a mix of FOBT and colonoscopy; or colonoscopy alone). Read the rest of this entry »



